Cargando…

Current Technologies for RNA-Directed Liquid Diagnostics

SIMPLE SUMMARY: The discovery of nucleic acids in blood has rapidly led into the development of methods for their isolation, characterisation and validation in the context of liquid biopsy. In this emerging field, miRNAs are promising biomarkers for the detection of solid tumours in the body fluids...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Dominguez, Maria Victoria, Zottel, Alja, Šamec, Neja, Jovčevska, Ivana, Dincer, Can, Kahlert, Ulf Dietrich, Nickel, Ann-Christin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534233/ https://www.ncbi.nlm.nih.gov/pubmed/34680210 http://dx.doi.org/10.3390/cancers13205060

Ejemplares similares

Non-animal glioblastoma models for personalized treatment
por: Zottel, Alja, et al.
Publicado: (2023)

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
por: Zottel, Alja, et al.
Publicado: (2020)

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020)

Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles
por: Colja, Sara, et al.
Publicado: (2023)

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas
por: Jovčevska, Ivana, et al.
Publicado: (2019)

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
por: Zottel, Alja, et al.
Publicado: (2020)

Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates
por: Vidak, Marko, et al.
Publicado: (2018)

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting
por: Samec, Neja, et al.
Publicado: (2018)

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
por: Zottel, Alja, et al.
Publicado: (2019)

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
por: Porčnik, Andrej, et al.
Publicado: (2021)

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma
por: Sorokin, Maxim, et al.
Publicado: (2021)

OligoPrime: An Information System for Oligonucleotide Management
por: Ravnik, Šimen, et al.
Publicado: (2021)

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
por: Zottel, Alja, et al.
Publicado: (2020)

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo
por: Zottel, Alja, et al.
Publicado: (2023)

Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas
por: Zolotovskaia, Marianna, et al.
Publicado: (2021)

Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery
por: Giesen, Beatriz, et al.
Publicado: (2021)

Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles
por: Krapež, Gloria, et al.
Publicado: (2022)

Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma
por: Jovčevska, Ivana
Publicado: (2020)

Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma
por: Vargas-Toscano, Andres, et al.
Publicado: (2020)

Testing the Stability of Drug Resistance on Cryopreserved, Gene-Engineered Human Induced Pluripotent Stem Cells
por: Khan, Dilaware, et al.
Publicado: (2021)

An inexpensive and easy-to-implement approach to a Quality Management System for an academic research lab
por: Hewera, Michael, et al.
Publicado: (2020)

Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells
por: Li, Guanzhang, et al.
Publicado: (2021)

CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells
por: Poonaki, Elham, et al.
Publicado: (2022)

Different Calculation Strategies Are Congruent in Determining Chemotherapy Resistance of Brain Tumors In Vitro
por: Fischer, Igor, et al.
Publicado: (2020)

Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
por: Jovčevska, Ivana, et al.
Publicado: (2017)

The Therapeutic Potential of Nanobodies
por: Jovčevska, Ivana, et al.
Publicado: (2019)

Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma
por: Mehrjardi, Narges Zare, et al.
Publicado: (2020)

Different Approaches to Study Molecular Blueprint and Biological Behavior of Brain Tumors: Editorial to the Special Issue “Advances in Molecular Genetics of Brain Tumors”
por: Pećina-Šlaus, Nives, et al.
Publicado: (2023)

Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide
por: Vargas-Toscano, Andres, et al.
Publicado: (2020)

Reducing sources of variance in experimental procedures in in vitro research
por: Fischer, Igor, et al.
Publicado: (2022)

Editorial: Integrated biosensors towards clinical and point-of-care diagnostics
por: Dincer, Can, et al.
Publicado: (2022)

EURISOL-DS Multi-MW Target: Design of the EURISOL Liquid metal loop
por: K. Samec (PSI)
Publicado: (23/0)

TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers
por: Jovčevska, Ivana, et al.
Publicado: (2014)

The Evolution of Affordable Technologies in Liquid Biopsy Diagnostics: The Key to Clinical Implementation
por: Alexandrou, George, et al.
Publicado: (2023)

A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma
por: Herrera-Rios, Dayana, et al.
Publicado: (2020)

Mpox diagnostics: Review of current and emerging technologies
por: Lim, Chuan Kok, et al.
Publicado: (2023)

Liquid biopsy: current technology and clinical applications
por: Nikanjam, Mina, et al.
Publicado: (2022)

eLabFTW as an Open Science tool to improve the quality and translation of preclinical research
por: Hewera, Michael, et al.
Publicado: (2021)

A Preclinical Pipeline for Translational Precision Medicine—Experiences from a Transdisciplinary Brain Tumor Stem Cell Project
por: Vargas-Toscano, Andres, et al.
Publicado: (2021)

The role of the ZEB1–neuroinflammation axis in CNS disorders
por: Poonaki, Elham, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vepj4ak64hb0pn0r3rb333ssid